Table 1.
Characteristics of admitted patients included in the study
| Variable | Pediatric patients | Adult patients | ||
|---|---|---|---|---|
| Negative | Positive | Negative | Positive | |
| (N = 172) | (N = 4) | (N = 279) | (N = 18) | |
| Male sex (%) | 101 (58.7) | 2 (50.0) | 157(56.3) | 10 (55.6) |
| Mean age, years (SD) | 4.1 (4.2) | 7.8 (5.1) | 54.1 (18.3) | 59.8 (22.7) |
| Transfer (%)# | 18 (10.5) | 0 (0.0) | 12 (4.3) | 2 (11.1) |
| Admission by ER (%) | 105 (61.0) | 2 (50.0) | 223 (79.9) | 15 (83.3) |
| Median LOS, days (IQR) | 8.0 (12.0) | 11.0 (32.0) | 11.0 (16.0) | 14.0 (12.0) |
| Hospital admission last year (%) Median N admissions(IQR)* |
116 (67.4) 1.0 (3.0) |
4 (100.0) 2.0 (5.0) |
163 (58.4) 1 (2.0) |
16 (88.9) 4(5.0) |
| Ambulatory care (%)§ | 27 (15.7) | 1 (25.0) | 50 (17.9) | 4 (22.2) |
| Previous MRSA (%) | 30 (17.4) | 2 (50.0) | 22 (7.9) | 1 (5.6) |
| Antimicrobials 2 wks before (%) | 66 (38.4) | 2 (50.0) | 75 (26.9) | 9 (50.0) |
| Corticosteroids 2 wks before (%) | 30 (17.4) | 1(25.0) | 23 (8.2) | 3 (16.7) |
| Immunosupressors 2 wks before (%) | 4 (2.3) | 0 (0.0) | 15 (5.4) | 0 (0.0) |
| Skin lesions (%) | 38 (22.1) | 1 (25.0) | 55 (19.7) | 3 (16.7) |
| HIV infection (%) | 5 (2.9) | 0 (0) | 31 (11.1) | 1 (5.6) |
| Diabetes mellitus (%) | 2 (1.2) | 1 (25.0) | 53 (19.0) | 4 (22.2) |
| Any neoplasia (%) | 33 (19.2) | 1 (25.0) | 4 (30.1) | 5 (27.8) |
| Pulmonary disease (%) | 37 (21.6) | 2 (50.0) | 31 (11.1) | 1 (5.6) |
ER: Emergency Room, LOS: length of stay, IQR: interquartile range, wks: weeks, MRSA: Methicillin-resistant Staphylococcus aureus HIV: human immunodeficiency virus
# Transfer from another hospital or long term care facility
* in patients with at least one admission in the last year
§ Ambulatory care due chronic condition: dialysis and/or chemotherapy and/or radiotherapy
¶ Cystic Fibrosis, Asthma or Chronic Obstructive Pulmonary Disease